The present study examined resting heart rate variability (HRV; an ind
ex of parasympathetic tone) and heart rate response to the Valsalva ma
neuver (Valsalva ratio; an index of overall autonomic responsiveness)
in 12 repeat users of 3,4-methylenedioxymethamphetamine (MDMA-''Ecstas
y''), and a matched comparison group of presumed nonusers. HRV and Val
salva ratio were smaller in users than in controls. Three out of 12 MD
MA users but no controls had Valsalva ratios below 1.50, the cut-off f
or autonomic dysfunction. In several users, there was a total absence
of post-Valsalva release bradycardia. All MDMA users were polydrug use
rs. Parasympathetic cardiovascular tone appears impaired in repeat MDM
A users, although the ubiquitous problems in such epidemiologic design
s (including lack of testing before the first use of the drug and conf
ounding with use of other drugs) preclude definitive causal interpreta
tions.